November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
November 11, 2011
November 11, 2011 – Biosensors International Group announced two-year results from the BioFreedom first-in-human trial ...
November 11, 2011
November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
November 11, 2011Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023
November 9, 2011 — Currently under review by the U.S. Food and Drug Administration (FDA), the Resolute drug-eluting ...
November 09, 2011
November 8, 2011 — Biosensors International Group Ltd. announced final results of the AXXESS PLUS trial, which ...
November 08, 2011
November 8, 2011 – Boston Scientific reports clinical endpoint data from its PLATINUM Long Lesion trial, demonstrating ...
November 08, 2011
November 7, 2011 – Abbott announced the company's schedule of key data presentations at the 23rd annual Transcatheter ...
November 07, 2011November 7, 2011 – Arterial Remodeling Technologies (ART) reported that in vivo data strongly suggest that its second ...
November 07, 2011
November 4, 2011 — Medtronic Inc. announced approval by the U.S. Food and Drug Administration (FDA) of the Assurant ...
November 04, 2011
Nov. 2, 2011 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Xience Prime everolimus ...
November 02, 2011November 1, 2011 – Boston Scientific released the schedule of its major events and product-related clinical research for ...
November 01, 2011
October 25, 2011 — Stentys S.A. announced the publication of the results of the APPOSITION I clinical study in the ...
October 25, 2011
October 24, 2011 — BioCrossroads’ Indiana Seed Fund has announced its twelfth investment, committing $300,000 to medical ...
October 24, 2011
October 18, 2011 — Abbott announced the investigational Absorb bioresorbable vascular scaffold (BVS) has been recognized ...
October 18, 2011
October 18, 2011 — Boston Scientific Corp. has begun a phased launch of its Promus Element everolimus-eluting platinum ...
October 18, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now